Dermatological complications and safety of anti-TNF treatments.

@article{Kerbleski2009DermatologicalCA,
  title={Dermatological complications and safety of anti-TNF treatments.},
  author={Joseph F Kerbleski and Alice Bendix Gottlieb},
  journal={Gut},
  year={2009},
  volume={58 8},
  pages={1033-9}
}
It has been reported that tumour necrosis factor (TNF) inhibitors have adverse sideeffects including infections, malignancies, demyelinating disease, and induction of autoimmune conditions. Dermatological complications of anti-TNF therapy include injection site reactions, cutaneous infections, allergic rashes, psoriasis, non-melanoma skin cancer (NMSC), and rare reports of lupus-like syndrome, erythema multiforme (EM), Steven’s Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). 

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Certolizumab pegol in rheumatoid arthritis: current update.

Expert opinion on biological therapy • 2014
View 3 Excerpts
Highly Influenced

Cutaneous side effects of TNF-alpha inhibitors.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG • 2017

Nebenwirkungen von TNF-alpha-Inhibitoren am Hautorgan.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG • 2017

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Perioperative management of medications for psoriasis and psoriatic arthritis: a review for the dermasurgeon.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] • 2008

Serious 1 November

S Kroesen, AF Widmer, A Tyndall
2008

Similar Papers

Loading similar papers…